FDA Inspection 1077038 — Merck Sharp & Dohme BV

Merck Sharp & Dohme BV — FEI 3002807658

The FDA completed an inspection of Merck Sharp & Dohme BV on December 6, 2018 in Haarlem. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 6, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Haarlem (Netherlands)